Statements (53)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
peptide
|
| gptkbp:approves |
gptkb:European_Union
gptkb:Russia gptkb:United_States |
| gptkbp:associatedWith |
improved quality of life
reduced symptoms enhanced recovery |
| gptkbp:availableIn |
vials
|
| gptkbp:clinicalTrials |
prescription required
conducted in adults conducted in children off-label use |
| gptkbp:contains |
neurotrophic factors
|
| gptkbp:contraindication |
allergy to components
|
| gptkbp:developedBy |
Russian_scientists
|
| gptkbp:dosageForm |
once daily
|
| gptkbp:formulation |
lyophilized powder
|
| gptkbp:hasFilm |
attention
learning memory |
| https://www.w3.org/2000/01/rdf-schema#label |
Cortexin
|
| gptkbp:impact |
10 days
|
| gptkbp:improves |
cognitive functions
|
| gptkbp:issuedBy |
injection
|
| gptkbp:marketedAs |
various brand names
|
| gptkbp:notableFeature |
gptkb:Dr._Kuznetsov
gptkb:Dr._Smirnov Dr. Ivanov Dr. Sokolov Dr._Petrov |
| gptkbp:origin |
animal brain
|
| gptkbp:patentStatus |
patented
commercially available |
| gptkbp:researchFocus |
pharmacology
neurobiology clinical efficacy |
| gptkbp:researchInterest |
needs further investigation
positive outcomes in studies variable results in different populations |
| gptkbp:sideEffect |
dizziness
headache nausea |
| gptkbp:storage |
refrigerated
|
| gptkbp:triggerType |
neuroprotective effects
|
| gptkbp:usedFor |
neurodegenerative diseases
traumatic brain injury cerebral palsy autism spectrum disorders treatment of neurological disorders post-stroke recovery |
| gptkbp:usedIn |
integrative medicine
alternative medicine rehabilitation therapy |